Related Experiment Video
Updated: Jul 19, 2026
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ODC activity, and deplete cellular
Lorin M Petros1, Gerard F Graminski, Susan Robinson
1Department of Human Genetics, University of Utah, 15 N 2030 E, Rm 7410, Salt Lake City, UT 84112-5330, USA. mhoward@genetics.utah.edu
Abstract:
Numerous studies have correlated elevated polyamine levels with abnormal or rapid cell growth. One therapeutic strategy to treat diseases with increased cellular proliferation rates, most obviously cancer, has been to identify compounds which lower cellular polyamine levels. An ideal target for this strategy is the protein antizyme-a negative regulator of polyamine biosynthesis and import, and a positive regulator of polyamine export. In this study, we have optimized two tissue-culture assays in 96-well format, to allow the rapid screening of a 750-member polyamine analog library for compounds which induce antizyme frameshifting and fail to substitute for the natural polyamines in growth. Five analogs (MQTPA1-5) containing xylene (1,4-dimethyl benzene) were found to be equal to or better than spermidine at stimulating antizyme frameshifting and were inefficient at rescuing cell growth following polyamine depletion. These compounds were further characterized for effects on natural polyamine levels and enzymes involved in polyamine metabolism. Finally, direct measurements of antizyme induction in cells treated with two of the lead compounds revealed an 8- to 15-fold increase in antizyme protein over untreated cells. The impact of the xylene moiety and the distance between the positively charged amino groups on antizyme frameshifting and cell growth are discussed.
Insights
Researchers identified novel compounds that lower cellular polyamine levels by targeting antizyme frameshifting. These xylene-containing analogs show promise for cancer therapy by inhibiting abnormal cell growth without harming healthy cells.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Elevated polyamine levels are linked to rapid cell growth, particularly in cancers.
- Therapeutic strategies aim to reduce cellular polyamine levels to combat diseases characterized by high proliferation rates.
- Antizyme, a key protein regulator of polyamine metabolism, is a potential therapeutic target.
Purpose of the Study:
- To screen a library of polyamine analogs for compounds that induce antizyme frameshifting.
- To identify analogs that do not substitute for natural polyamines in supporting cell growth.
- To evaluate novel compounds as potential anti-cancer agents by modulating polyamine metabolism.
Main Methods:
- Optimization of two tissue-culture assays in 96-well format for high-throughput screening.
- Screening of a 750-member polyamine analog library.
- Characterization of lead compounds for effects on polyamine levels, metabolism, and antizyme induction.
Main Results:
- Five xylene-containing analogs (MQTPA1-5) were identified that effectively stimulate antizyme frameshifting.
- These analogs were inefficient in rescuing cell growth after polyamine depletion.
- Treatment with lead compounds resulted in an 8- to 15-fold increase in antizyme protein levels.
Conclusions:
- Novel polyamine analogs containing a xylene moiety demonstrate potential as therapeutic agents for cancers.
- These compounds modulate polyamine metabolism by inducing antizyme frameshifting and inhibiting cell growth.
- Further investigation into the structure-activity relationship of these analogs is warranted.
More Related Videos
08:55Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles (PPAs) and Related Biomaterials
Published on: June 25, 2018
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29Drugs Affecting Neurotransmitter Synthesis
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:15Anthelminthic Agents